An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma

Table 1 Ten lncRNAs and eight mRNAs selected as prognostic RNAs

Type	ID	coefficient	P-value	HR	95%CI	X-tile cutoff
lncRNA	HOXB-AS3	0.074	0.007	1.350	1.086–1.676	0.87
	LGALS8-AS1	0.122	0.014	1.292	1.053–1.584	0.20
	LINC00032	−0.003	0.020	0.795	0.656–0.963	0.20
	LINC00311	0.060	0.001	1.481	1.173–1.868	−2.01
	LINC00494	−0.004	0.013	0.842	0.672–0.952	−0.14
	LINC00544	0.021	0.021	1.265	1.035–1.543	0.02
	LINC00589	0.067	0.019	1.147	0.934–1.407	0.00
	LINC00626	−0.005	0.018	0.770	0.619–0.956	0.00
	MEIS1-AS3	−0.053	0.040	0.803	0.650–0.989	0.15
	VAV3-AS1	0.104	0.042	1.225	0.998–1.502	−0.09
mRNA	ASIC5	0.065	0.035	1.246	1.016–1.528	−1.67
	CGB7	0.072	0.003	1.405	1.124–1.756	−0.47
	CLDN16	0.123	0.006	1.372	1.096–1.717	−2.39
	HAPLN4	0.143	0.000	1.518	1.228–1.877	−2.03
	KRT13	0.084	0.002	1.362	1.123–1.652	−0.01
	LCN9	0.059	0.012	1.300	1.060–1.595	−0.22
	SOST	0.033	0.018	1.148	1.038–1.404	0.60
	TNS4	0.028	0.041	1.231	1.009–1.503	−0.14

ISSN: 1471-2350